The decreased mechanistic target of rapamycin (mTOR) protein levels regulated by miR-342 can explain the abnormal pancreas β cell mass and function in offspring (108), causing permanent changes that may contribute to the MetS later in life. This evidence concerns the gene MTOR and metabolic syndrome.